DA-5204

· Dong-A ST Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DA-5204, covering 2014-11-04 to 2019-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of DA-5204 on Gastroesophageal Reflux Disease [Phase 3]